Company attributes
Industry
B2X
CEO
Founder
AngelList URL
Legal Name
Kite Pharma, Inc.
Parent Organization
Subsidiary
Number of Employees (Ranges)
11 – 500
Email Address
public_affairs@kitepharma.com0
Phone Number
+131082499990
Number of Employees
2,000
Full Address
2400 Broadway Santa Monica, CA 904040
CIK Number
Place of Incorporation
Investors
DUNS Number
9633533590
Founded Date
2014
0Total Funding Amount (USD)
30,250,000
Latest Funding Round Date
May 2013
Stock Symbol
KITE
Exchange
Latest Funding Type
CAGE Code
6WJU50
Wellfound ID
Country
Headquarters
Other attributes
Acquirer
Blog
Company Operating Status
Active
Invested in
SIC Code
2,8360
Wikidata ID
Gilead Sciences and Kite Pharma acquired Cell Design Labs in 2017. synNotch technology was developed in the lab of Wendell Lim at UC San Francisco and further developed by Cell Design Labs, to rewire immune cells and create customized cells that can carry out highly specialized actions in the body. synNotch technology can be applied to therapeutics for cancer, autoimmune and infectious diseases. A collaboration between Kite's parent company, Gilead and Kyverna aims to treat autoimmune disease using Kyverna’s Treg platform and Kite’s synNotch technology.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
